There are differences in prostate cancer treatment intensification adoption between academic and nonacademic physicians.
Symptom scores remained stable over time, with similar QOL trends in both treatment arms.
Among patients in the real world with unresectable or metastatic urothelial carcinoma, Padcev significantly improved overall ...
Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for ...
Final results were consistent with previously conducted research in patients with advanced renal cell carcinoma treated with ...
Among patients with clear cell renal cell carcinoma, improved responses were observed with Lenvima plus Welireg versus ...
Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.
Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...
Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...
I found community after my metastatic breast cancer diagnosis, but recent discord in cancer support groups makes me fear ...
Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...
Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results